Konstantin Michailovich Loban

Konstantin Michailovich Loban

Auto-generated profile, based on publicly available information

Konstantin Michailovich Loban

Pirogov Russian National Research Medical University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2024 in Updates in Surgery
Verified
Journal Article
Closed access
PDF file
ATAlexander Evgenievich Tyagunov
Alexander Evgenievich Tyagunov
MAMichael Anurov
Michael Anurov
STSvetlana Michailovna Titkova
Svetlana Michailovna Titkova
LKLiana Sultanovna Kurashinova
Liana Sultanovna Kurashinova
KLKonstantin Michailovich Loban
Konstantin Michailovich Loban
ASAlexander Vyacheslavovich Sazhin
Alexander Vyacheslavovich Sazhin

16 October 2024 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
AOA. S. Ostrovskaya
A. S. Ostrovskaya
MMM. V. Maevskaya
M. V. Maevskaya
KLK. M. Loban
K. M. Loban
ZMZharkova Maria
Zharkova Maria
MSM. P. Shapka
M. P. Shapka
VIVladimir Ivashkin
Vladimir Ivashkin
Introduction. The use of hypoammonemic agents to treat sarcopenia in liver cirrhosis has the potential to positively affect muscle mass, strength and function, given the pathogenetic basis of sarcopenia in liver cirrhosis.Aim. To compare muscle mass, strength and function, as well as capillary blood ammonia levels in patients with decompensated liver cirrhosis in two groups with and without use of L-ornithine-L-aspartate (LOLA).Materials and methods. A prospective cohort study was conducted. The treatment group included patients with decompensated liver cirrhosis of various etiologies and hyperammonemia, who received a hypoammonemic agent (LOLA) as part of complex therapy; the comparator group included patients with liver cirrhosis, hyperammonemia and sarcopenia, who did not receive LOLA. All patients underwent measurements of muscle mass (shoulder muscle volume, skeletal muscle mass indices (SMI) measured by dual-energy X-ray absorptiometry), strength (dynamometry, chair stand test) and function (short physical performance battery).Results. An analysis of clinical outcomes included 42 patients: 30 from the treatment group and 12 from the comparator group. In the treatment group, the proportion of patients with reduced muscle mass decreased from 76.67% to 73.33% (p = 0.012).The average shoulder muscle volume in the treatment group was 20.86 cm, which reached 21.35 cm (p = 0.072) at 3 months of therapy. The growth in shoulder muscle values and changes in the skeletal muscle indices for the upper limbs showed an increase in muscle mass. In the treatment group, mean muscle mass values measured by handheld dynamometry (HHD) increased from 20.53 to 22.48 kg at 3 months of therapy (p = 0.011). The increase in dynamometry scores demonstrated an increase in muscle strength during LOLA therapy. The increase in balance test scores determining muscle function was reported (p < 0.001). The capillary blood ammonia levels did not change significantly in both groups.Conclusion. The study showed a significant increase in muscle mass, strength and function in patients with liver cirrhosis and hyperammonemia, receiving LOLA as part of decompensated liver cirrhosis therapy.


22 September 2022 in Surgical Practice
Verified
Journal Article
Open access
PDF file
IBIa. A. Burenkov
Ia. A. Burenkov
NGN. S. Glagolev
N. S. Glagolev
GIG. B. Ivakhov
G. B. Ivakhov
AAA. V. Andriyashkyn
A. V. Andriyashkyn
KLK. M. Loban
K. M. Loban
ASA. V. Sazhin
A. V. Sazhin
The problem of treatment of incisional ventral hernias is currently very relevant. The appearance of a hernial defect in the area of a previous operation is one of the most frequent long-term complications of any surgical treatment. Component separation techniques are the most modern and promising methods for the treatment of large ventral hernias. The review focuses on the main stages in the development of separation technique, as well as the results of treating patients with incisional ventral hernias using various options for posterior separation repair, which are currently frequently used. It has been established that posterior component separation is an effective and safe method of treatment, however, there is currently insufficient data on the long-term postoperative period and patients quality of life.

24 December 2020 in Novosti Khirurgii
Verified
Journal Article
Closed access
PUPirogov Russian National Research Medical University
Pirogov Russian National Research Medical University
АSА.V. Sazhin
А.V. Sazhin
КLК.M. Loban
К.M. Loban
GIG.B. Ivakhov
G.B. Ivakhov
VPV.A. Petukhov
V.A. Petukhov
RAR.R. Akhmedov
R.R. Akhmedov
Лечение грыж является одним из самых древних разделов хирургии, и по настоящее время его развитие стремительно продолжается. В последние годы в арсенале хирургов появился целый ряд новых технологий, которые нашли свое место и в герниологии. Несмотря на бурное развитие хирургии грыж, сохраняется ряд дискуссионных вопросов. Не определена роль предоперационных методов обследования в алгоритме выбора метода лечения. Не существует однозначного мнения относительно пространств, в которые следует имплантировать сетчатый имплант, а также того, насколько выполнимы и целесообразны малоинвазивные методы. Кроме того, нет консенсуса по вопросам терминологии, используемой в современной герниологии. В данной статье затронуты эпидемиологические и исторические аспекты хирургии вентральных грыж, рассмотрены актуальные представления об анатомии передней брюшной стенки, современная терминология и классификации, описаны методы предоперационной подготовки и обследования пациентов с вентральными грыжами, показания к хирургическому лечению, разобраны существующие хирургические опции. На сегодняшний день остается актуальным проведение поисков наиболее физиологичных и функциональных методов лечения вентральных грыж, обеспечивающих минимальный риск рецидива и осложнений и повышающих качество жизни пациентов.

1 January 2018 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
PDF file
ASA. V. Sazhin
A. V. Sazhin
GIG. B. Ivakhov
G. B. Ivakhov
AAA. V. Andriyashkin
A. V. Andriyashkin
VMV. A. Mamadumarov
V. A. Mamadumarov
ANA. S. Nikishkov
A. S. Nikishkov
KLK. M. Loban
K. M. Loban
Medical article медицинская статья